Hematopoietic stem cells (HSCs) are regarded as one of essential cell sources for treating
regenerative diseases. Among many stem cells, the feasibility of using adult-derived …

Liver fibrosis is an outcome of many chronic diseases, and often results in cirrhosis, liver
failure, and portal hypertension. Liver transplantation is the only treatment available for …

BACKGROUND & AIMS: Acute-on-chronic liver failure (ACLF) develops in patients with
chronic liver disease and has high mortality. Mobilization of bone marrow–derived stem cells …

Background End-stage liver disease is a medical problem with high morbidity and mortality.
We have investigated the feasibility, safety, and efficacy of using autologous mesenchymal …

OBJECTIVES: Severe alcoholic hepatitis has high short-term mortality. The aim of this study
was to test the hypothesis that treatment of patients with alcoholic hepatitis with granulocyte …

Background Results of small-scale studies have suggested that stem-cell therapy is safe
and effective in patients with liver cirrhosis, but no adequately powered randomised …

Liver failure is the major cause of death in alcoholic steatohepatitis (ASH). In experimental
hepatitis, granulocyte‐colony stimulating factor (G‐CSF) mobilizes hematopoietic stem cells …

Tissue progenitor cells are an attractive target for regenerative therapy. In various organs,
bone marrow cell (BMC) therapy has shown promising preliminary results, but to date no …

AIM: To evaluate safety and feasibility of autologous bone marrow-enriched CD34+
hematopoietic stem cell Tx through the hepatic artery in patients with decompensated …

Background—Understanding the mechanisms of repair and regeneration of the kidney after
injury is of great interest because there are currently no therapies that promote repair, and …